| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...986871S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0086871 |
| P932 | PMC publication ID | 3899311 |
| P698 | PubMed publication ID | 24466274 |
| P5875 | ResearchGate publication ID | 259920463 |
| P2093 | author name string | Jie Liu | |
| Hongbo Liu | |||
| Min Song | |||
| Tianren Li | |||
| Wenjing Shen | |||
| Yanjie Hu | |||
| Guangrong Qiu | |||
| P2860 | cites work | MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets | Q57200273 |
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β | Q24610983 | ||
| Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Circulating microRNAs in cancer: origin, function and application | Q27013716 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
| The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 | ||
| MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
| Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study | Q33623349 | ||
| OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 | ||
| MicroRNAs in cell proliferation, cell death, and tumorigenesis. | Q34497050 | ||
| Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival | Q35173163 | ||
| Estrogens and epithelial ovarian cancer | Q35840390 | ||
| Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer | Q36657641 | ||
| Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases | Q36796731 | ||
| Oncoviruses and Pathogenic MicroRNAs in Humans | Q37634314 | ||
| microRNAs: Master Regulators as Potential Therapeutics in Cancer | Q37784515 | ||
| Prospective on ovarian cancer: why prevent? | Q41070247 | ||
| The quantification of tomato microRNAs response to viral infection by stem-loop real-time RT-PCR. | Q43406654 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | e86871 | |
| P577 | publication date | 2014-01-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MiR-26a promotes ovarian cancer proliferation and tumorigenesis | |
| P478 | volume | 9 |
| Q45777871 | A combination of circulating miRNAs for the early detection of ovarian cancer |
| Q26753467 | An overview of long non-coding RNAs in ovarian cancers |
| Q64083820 | Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis |
| Q33718986 | Circulating MicroRNAs in gynecological malignancies: from detection to prediction |
| Q92286877 | Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer |
| Q38711390 | Current status on microRNAs as biomarkers for ovarian cancer |
| Q38938771 | Global 3' UTR shortening has a limited effect on protein abundance in proliferating T cells |
| Q33689551 | Identification and comparative analysis of the ovarian microRNAs of prolific and non-prolific goats during the follicular phase using high-throughput sequencing |
| Q55716532 | Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells. |
| Q54989577 | Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. |
| Q58571301 | Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q38960631 | MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2. |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q41997354 | MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity |
| Q35678702 | MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways |
| Q92839221 | MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells |
| Q49790324 | MicroRNA-26a and Tumor |
| Q55042929 | MicroRNA-26a inhibits hyperplastic scar formation by targeting Smad2. |
| Q50617687 | MicroRNAome of porcine conceptuses and trophoblasts: expression profile of micrornas and their potential to regulate genes crucial for establishment of pregnancy. |
| Q39333266 | MicroRNAs in gynecological cancers: Small molecules with big implications |
| Q48563610 | Plasma miR-454-3p as a potential prognostic indicator in human glioma |
| Q92636165 | Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview |
| Q36210966 | Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma |
| Q52862916 | Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer. |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q53539464 | miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma. |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q36954415 | miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2. |
| Q38667018 | microRNA and Ovarian Cancer |
Search more.